Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Rajinder Kumar Suri"'
Autor:
Rajinder Kumar Suri, Aila Marini
Publikováno v:
Vaccine: X, Vol 19, Iss , Pp 100504- (2024)
The 24th Annual General Meeting of the Developing Countries Vaccine Manufacturers’ Network (DCVMN), held in Cape Town, South Africa and co-hosted by Biovac, convened over 400 delegates and featured more than 100 distinguished speakers across three
Externí odkaz:
https://doaj.org/article/521fd191f6f04d9ba0eac6e3965cf7fd
Autor:
Rajinder Kumar Suri, Aila Marini
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100353- (2023)
The 23rd Annual General Meeting of the Developing Countries Vaccine Manufacturers’ Network (DCVMN), co-hosted by Serum Institute of India (SII), gathered over 365 delegates and more than 90 high-level speakers for three days of presentations, discu
Externí odkaz:
https://doaj.org/article/4c95ca4543574ddab8909801b897566c
Publikováno v:
Vaccine. 40:3495-3505
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0e1f71ddeb434822da54d48075505cd
https://doi.org/10.1016/j.vaccine.2022.05.006
https://doi.org/10.1016/j.vaccine.2022.05.006
Autor:
Frank Cobelens, Rajinder Kumar Suri, Michelle Helinski, Michael Makanga, Ana Lúcia Weinberg, Britta Schaffmeister, Frank Deege, Mark Hatherill
Publikováno v:
The Lancet Infectious Diseases. 22:e108-e120
To eliminate tuberculosis globally, a new, effective, and affordable vaccine is urgently needed, particularly for use in adults and adolescents in low-income and middle-income countries. We have created a roadmap that lists the actions needed to acce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31f3673f0ce0f0ebfcff8462d815f94
https://doi.org/10.1016/s1473-3099(21)00810-0
https://doi.org/10.1016/s1473-3099(21)00810-0
Publikováno v:
Vaccine. 40(50)
The sustainable manufacturing of vaccines in developing countries is critical to increasing equitable access to vaccines and pandemic preparedness globally. Sustainable manufacturing requires that organizations engaged in the development, production
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063bae68debbacd6664ceef712cab40f
https://pubmed.ncbi.nlm.nih.gov/36334966
https://pubmed.ncbi.nlm.nih.gov/36334966
Publikováno v:
Vaccine
Vaccine manufacturers from developing countries have a proven track record of developing, producing, and supplying high-quality vaccines globally. However, due to the complexity of vaccine manufacturing, numerous stakeholder organizations support man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8356f58dc81bed978d314b0dcb8dc7a4
https://pubmed.ncbi.nlm.nih.gov/34325932
https://pubmed.ncbi.nlm.nih.gov/34325932
Autor:
Suresh Jadhav, Rajinder Kumar Suri, Ching-Chia Ting, Sonia Pagliusi, Li Meng, Patrick Tippoo, Sumana Khomvilai, Steven Gao, Akira Homma, Pan Hong Thai, Mahendra Suhardono, Vitoon Vonghangool, Ray Prasad
Publikováno v:
Vaccine. 34(31):3562-3567
The Developing Countries Vaccine Manufacturers Network (DCVMN) assembled high-profile leaders from global health organisations and vaccine manufactures for its 16th Annual General Meeting to work towards a common goal: providing quality vaccines for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3c7a5335614ebae9908fac2b33f00e9
Publikováno v:
Vaccine. 33:2197-2202
The Developing Countries Vaccine Manufacturers’ Network (DCVMN) held its fifteenth annual meeting from October 27–29, 2014, New Delhi, India. The DCVMN, together with the co-organizing institution Panacea Biotec, welcomed over 240 delegates repre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f238a1f96420275dee2269f50d45705
https://doi.org/10.1016/j.vaccine.2015.02.065
https://doi.org/10.1016/j.vaccine.2015.02.065
Autor:
Harjinder Singh, Surinder Bazaz, Rajinder Kumar Suri, Krishna Shivaprakash, RS Dhaliwal, Harshbir Singh Pannu, J. S. Gujral, Harinder Singh Bedi
Publikováno v:
Journal of Cardiac Surgery. 10:316-324
From 1981 to 1992, 13 male and 7 female patients underwent surgical correction for ruptured aneurysms of sinus of valsalva. A total surgical experience of 22 procedures including 2 reoperations is presented, accounting for 1.37% of open heart surgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ddefa980b0f7c29f88b855be27d385
https://doi.org/10.1111/j.1540-8191.1995.tb00618.x
https://doi.org/10.1111/j.1540-8191.1995.tb00618.x
Publikováno v:
Panacea Biotec Ltd MarketLine Company Profile. 4/8/2022, p1-22. 22p.